Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination. (6th November 2014) - Datta, Jashodeep; Xu, Shuwen; Terhune, Julia H; Rosemblit, Cinthia; Berk, Erik; Fitzpatrick, Elizabeth; Czerniecki, Brian J